期刊文献+
共找到665篇文章
< 1 2 34 >
每页显示 20 50 100
Comparative dissolution study on counterfeit medicines of PDE-5 inhibitors
1
作者 E.Deconinck S.Andriessens +2 位作者 J.L.Bothy P.Courselle J.O.De Beer 《Journal of Pharmaceutical Analysis》 SCIE CAS 2014年第4期250-257,共8页
Counterfeit medicines are a growing problem in both developing and industrialised countries. In general the evaluation of these medicines is limited to the identification and the dosage of the active ingredients. In t... Counterfeit medicines are a growing problem in both developing and industrialised countries. In general the evaluation of these medicines is limited to the identification and the dosage of the active ingredients. In this study in vitro dissolution tests were conducted on two sets of counterfeit medicines containing PDE-5 inhibitors (sildenafil citrate and tadalafil). The dissolution profiles were statistically compared to the ones of the genuine products using the f2-method and a comparison at each time point using the Cochran test. The results showed low equivalences between counterfeit and genuine products as well as higher variations around the mean dissolution value at the different time points for the counterfeit products. 展开更多
关键词 COUNTERFEIT pde-5 inhibitors In vitro dissolution f2-Method Cochran test
下载PDF
Long noncoding RNAs HAND2-AS1 ultrasound microbubbles suppress hepatocellular carcinoma progression by regulating the miR-873-5p/tissue inhibitor of matrix metalloproteinase-2 axis
2
作者 Qiang Zou Hao-Wen Wang +2 位作者 Xi-Liang Di Yuan Li Hui Gao 《World Journal of Gastrointestinal Oncology》 SCIE 2024年第4期1547-1563,共17页
BACKGROUND Increasing data indicated that long noncoding RNAs(lncRNAs)were directly or indirectly involved in the occurrence and development of tumors,including hepatocellular carcinoma(HCC).Recent studies had found t... BACKGROUND Increasing data indicated that long noncoding RNAs(lncRNAs)were directly or indirectly involved in the occurrence and development of tumors,including hepatocellular carcinoma(HCC).Recent studies had found that the expression of lncRNA HAND2-AS1 was downregulated in HCC tissues,but its role in HCC progression is unclear.Ultrasound targeted microbubble destruction mediated gene transfection is a new method to overexpress genes.AIM To study the role of ultrasound microbubbles(UTMBs)mediated HAND2-AS1 in the progression of HCC,in order to provide a new reference for the treatment of HCC.METHODS In vitro,we transfected HAND2-AS1 siRNA into HepG2 cells by UTMBs,and detected cell proliferation,apoptosis,invasion and epithelial-mesenchymal transition(EMT)by cell counting kit-8 assay,flow cytometry,Transwell invasion assay and Western blotting,respectively.In addition,we transfected miR-837-5p mimic into UTMBs treated cells and observed the changes of cell behavior.Next,the UTMBs treated HepG2 cells were transfected together with miR-837-5p mimic and tissue inhibitor of matrix metalloproteinase-2(TIMP2)overexpression vector,and we detected cell proliferation,apoptosis,invasion and EMT.In vivo,we established a mouse model of subcutaneous transplantation of HepG2 cells and observed the effect of HAND2-AS1 silencing on tumor formation ability.RESULTS We found that UTMBs carrying HAND2-AS1 restricted cell proliferation,invasion,and EMT,encouraged apoptosis,and HAND2-AS1 silencing eliminated the effect of UTMBs.Additionally,miR-873-5p targets the gene HAND2-AS1,which also targets the 3’UTR of TIMP2.And miR-873-5p mimic counteracted the impact of HAND2-AS1.Further,miR-873-5p mimic solely or in combination with pcDNA-TIMP2 had been transformed into HepG2 cells exposed to UTMBs.We discovered that TIMP2 reversed the effect of miR-873-5p mimic caused by the blocked signalling cascade for matrix metalloproteinase(MMP)2/MMP9.In vivo results showed that HAND2-AS1 silencing significantly inhibited tumor formation in mice.CONCLUSION LncRNA HAND2-AS1 promotes TIMP2 expression by targeting miR-873-5p to inhibit HepG2 cell growth and delay HCC progression. 展开更多
关键词 Hepatocellular carcinoma Ultrasound microbubbles Long noncoding RNA HAND2-AS1 miR-873-5p Tissue inhibitor of matrix metalloproteinase-2
下载PDF
负压吸引联合PDE-5i治疗糖尿病性勃起功能障碍的临床观察
3
作者 张凯 王宁宁 +2 位作者 马楠 郭绍永 李虎 《安徽医专学报》 2023年第5期30-32,共3页
目的:探讨针对糖尿病性勃起功能障碍(DIED),负压吸引装置(VED)与PDE-5i联合治疗的有效性与安全性。方法:抽取60例DIED患者,采用随机数字表法随机分成治疗组和对照组,每组各30例,对照组:他达拉非5 mg,口服,每日1次,1个疗程为8周。治疗组... 目的:探讨针对糖尿病性勃起功能障碍(DIED),负压吸引装置(VED)与PDE-5i联合治疗的有效性与安全性。方法:抽取60例DIED患者,采用随机数字表法随机分成治疗组和对照组,每组各30例,对照组:他达拉非5 mg,口服,每日1次,1个疗程为8周。治疗组:他达拉非5 mg,口服,每日1次,在此治疗的基础上联合VED(每周3次,连续8周)治疗;观察患者的IIEF-5评分,未勃起时阴茎长度和周径,勃起硬度等级,患者和配偶在治疗前和治疗后的性生活满意度。结果:对照组治疗后阴茎长度和周径无明显改善(P>0.05);经治疗组处理后,上述指标较以前有所改善(P<0.05)。两组患者治疗后IIEF-5评分、阴茎勃起硬度和患者及配偶满意度均较治疗前有所提高(P<0.05),与对照组(P<0.05)相比,治疗组(P<0.05)的改善程度明显优于对照组,两组间差异有统计学意义(P<0.05)。结论:负压吸引联合PDE-5i治疗方案能使DIED患者阴茎长度和周径及勃起硬度有明显改善,其IIEF-5评分提高,使患者及配偶对性生活满意度提高,对勃起信心增强,疗效确切,无明显副作用,是目前临床上较好的治疗方法之一,值得临床推广应用。 展开更多
关键词 负压吸引 pde-5i 糖尿病 勃起功能障碍
下载PDF
PRMT5和CDKN2B在宫颈癌组织的表达及临床意义
4
作者 胡晓菡 周强 +3 位作者 孙武 陈静 沈瀚 李强 《疑难病杂志》 CAS 2024年第4期412-417,共6页
目的研究蛋白精氨酸甲基转移酶5(PRMT5)、细胞周期蛋白依赖性激酶抑制剂2B(CDKN2B)在宫颈癌中的表达及临床意义。方法收集2019年3月—2020年3月南京大学医学院附属鼓楼医院妇产科诊治宫颈癌患者88例。免疫组织化学法检测宫颈癌和癌旁组... 目的研究蛋白精氨酸甲基转移酶5(PRMT5)、细胞周期蛋白依赖性激酶抑制剂2B(CDKN2B)在宫颈癌中的表达及临床意义。方法收集2019年3月—2020年3月南京大学医学院附属鼓楼医院妇产科诊治宫颈癌患者88例。免疫组织化学法检测宫颈癌和癌旁组织中PRMT5、CDKN2B表达;采用Spearman相关分析PRMT5与CDKN2B表达的相关性;比较不同临床特征宫颈癌癌组织中PRMT5、CDKN2B表达的差异;Kaplan-Meier曲线评估PRMT5、CDKN2B表达对宫颈癌患者无进展生存预后的影响;多因素Cox回归分析宫颈癌患者无进展生存预后的影响因素。结果癌组织中PRMT5蛋白阳性率70.45%(62/88),高于癌旁组织6.82%(6/88)(χ^(2)=75.155,P<0.001)。宫颈癌组织中CDKN2B阳性率22.73%(20/88),低于癌旁组织79.55%(71/88)(χ^(2)=75.336,P<0.001)。宫颈癌中PRMT5与CDKN2B呈负相关(r=-0.734,P<0.001)。FIGOⅠB2~ⅡA期、有淋巴结转移宫颈癌组织中PRMT5阳性率高于FIGOⅠA~ⅠB1期、无淋巴结转移者,而CDKN2B阳性率则降低(χ^(2)/P=6.359/0.012、4.606/0.032、5.205/0.023、3.893/0.048)。PRMT5阳性组3年累积无进展生存率74.19%(46/62),低于PRMT5阴性组92.31%(24/26)(Log-Rankχ^(2)=4.386,P=0.017)。CDKN2B阴性组3年累积无进展生存率75.00%(51/68),低于CDKN2B阳性组95.00%(19/20)(Log-Rankχ^(2)=4.423,P=0.012)。FIGO分期ⅠB2~ⅡA期、合并淋巴结转移、PRMT5阳性、CDKN2B阴性是影响宫颈癌患者无进展生存预后的独立危险因素[OR(95%CI)=1.407(1.159~1.696),1.464(1.201~1.784),1.614(1.189~2.192),1.595(1.191~2.136)]。结论宫颈癌组织中PRMT5表达升高,CDKN2B表达降低,两者与宫颈癌患者的不良临床病理特征有关,是评估宫颈癌预后的标志物。 展开更多
关键词 宫颈癌 蛋白精氨酸甲基转移酶5 细胞周期蛋白依赖性激酶抑制剂2B 预后 肿瘤标志物
下载PDF
磷酸二酯酶5在心力衰竭中作用的研究进展
5
作者 杨洋 张雅茸 +2 位作者 杨红琴 王婧 赵红梅 《基础医学与临床》 CAS 2024年第5期724-728,共5页
磷酸二酯酶5(PDE5)是环磷酸鸟苷(cGMP)特异性水解酶,是由一氧化氮(NO)激活的可溶性鸟苷酸环化酶(sGC)靶向cGMP产生的。PDE5催化cGMP中磷酸二酯键的水解,从而将cGMP转化为无活性的5′-GMP形式,cGMP-PKG轴功能障碍将引起心脏重塑,是心力衰... 磷酸二酯酶5(PDE5)是环磷酸鸟苷(cGMP)特异性水解酶,是由一氧化氮(NO)激活的可溶性鸟苷酸环化酶(sGC)靶向cGMP产生的。PDE5催化cGMP中磷酸二酯键的水解,从而将cGMP转化为无活性的5′-GMP形式,cGMP-PKG轴功能障碍将引起心脏重塑,是心力衰竭(HF)的主要原因之一。但PDE5抑制剂治疗心力衰竭的临床疗效存在争议。本文总结了近年来PDE5在心力衰竭中的作用机制和研究进展,对未来临床应用PDE5靶向治疗心力衰竭具有重要的指导意义。 展开更多
关键词 心力衰竭 磷酸二酯酶5 磷酸二酯酶抑制剂 环磷酸鸟苷
下载PDF
老年经皮冠状动脉介入治疗术后支架内再狭窄患者胱抑素C、基质金属蛋白酶抑制剂-1、分泌型卷曲相关蛋白5表达及临床意义
6
作者 邸杰 李新政 张晓敬 《心脑血管病防治》 2024年第1期21-25,共5页
目的探讨老年经皮冠状动脉介入治疗(PCI)术后支架内再狭窄(ISR)患者胱抑素C(CysC)、基质金属蛋白酶抑制剂-1(TIMP-1)、分泌型卷曲相关蛋白5(SFRP-5)表达及对靶血管病变的预测价值。方法选取2020年5月至2022年5月保定市第一中心医院PCI术... 目的探讨老年经皮冠状动脉介入治疗(PCI)术后支架内再狭窄(ISR)患者胱抑素C(CysC)、基质金属蛋白酶抑制剂-1(TIMP-1)、分泌型卷曲相关蛋白5(SFRP-5)表达及对靶血管病变的预测价值。方法选取2020年5月至2022年5月保定市第一中心医院PCI术后1年内发生ISR的65例老年冠心病患者作为观察组,选取同期65例PCI术后1年内未发生ISR的老年冠心病患者作为对照组,比较两组一般资料、术后血清CysC、TIMP-1、SFRP-5水平,分析血清CysC、TIMP-1、SFRP-5水平与ISR发生的相关性,并比较观察组不同Mehran分型患者血清CysC、TIMP-1、SFRP-5水平,分析各指标水平与Mehran分型的相关性,分析血清CysC、TIMP-1、SFRP-5水平预测靶血管发生ISR的价值。结果观察组血清CysC水平高于对照组(t=6.949,P<0.05),TIMP-1、SFRP-5水平低于对照组(t=7.301、8.765,P<0.05);血清CysC水平与ISR的发生呈正相关(r=0.587,P<0.05),TIMP-1、SFRP-5水平与ISR的发生呈负相关(r=-0.609、-0.640,P<0.05)。观察组四种Mehran分型的患者CysC、TIMP-1、SFRP-5水平差异有统计学意义(F=10.759、8.326、19.764,P<0.05)。随着Mehran分型Ⅰ型到Ⅳ型的变化,CysC水平逐渐升高,TIMP-1、SFRP-5水平逐渐下降,差异有统计学意义(P<0.05)。血清CysC水平与ISR患者Mehran分型呈正相关关系(r=0.722,P<0.05),TIMP-1、SFRP-5水平与Mehran分型呈负相关关系(r=-0.799、-0.826,P<0.05)。血清CysC、TIMP-1、SFRP-5水平预测老年冠心病患者PCI术后1年内靶血管发生ISR的曲线下面积(AUC)分别为0.807(95%CI=0.729~0.871)、0.786(95%CI=0.706~0.853)、0.811(95%CI=0.733~0.874),联合预测的AUC最大,为0.943(95%CI=0.887~0.976)。结论老年冠心病PCI术后患者血清CysC水平升高,TIMP-1、SFRP-5水平降低与ISR的发生发展相关,术后早期检测各指标水平有助于预测靶血管发生ISR风险。 展开更多
关键词 冠心病 经皮冠状动脉介入治疗 支架内再狭窄 胱抑素C 基质金属蛋白酶抑制剂-1 分泌型卷曲相关蛋白5
下载PDF
PDE-5i联合AVSS RigiScan检测对ED患者特征及PCDU综合评估的分析 被引量:1
7
作者 黄十佳 马玲 《中国循证心血管医学杂志》 2023年第3期357-360,363,共5页
目的采用阴茎血流彩色多普勒超声(PCDU)对磷酸二酯酶5抑制剂(PDE-5i)联合听视觉性刺激(AVSS)阴茎硬度测量仪(RigiScan)检测异常的阴茎勃起功能障碍(ED)患者特征进行综合评估,探讨PCDU在ED评估中的临床价值。方法选择2014年1月至2021年1... 目的采用阴茎血流彩色多普勒超声(PCDU)对磷酸二酯酶5抑制剂(PDE-5i)联合听视觉性刺激(AVSS)阴茎硬度测量仪(RigiScan)检测异常的阴茎勃起功能障碍(ED)患者特征进行综合评估,探讨PCDU在ED评估中的临床价值。方法选择2014年1月至2021年10月就诊于中国中医科学院西苑医院男科诊断为ED且行PDE-5i联合AVSS的RigiScan检测结果为异常的患者共1477例,平均年龄(36.16±9.39)岁,平均病程(33±9.12)月,所有患者均完成PCDU检查。结果根据PCDU诊断标准将受检者分为四组:非血管性ED组611例(41%)、动脉性ED组266例(18%)、静脉性ED组375例(26%)和动静脉混合性ED组225例(15%),对四组患者一般特征及各项PCDU指标进行多组间比较。其中,除各组间病程无统计学差异外,各组间年龄、右侧阴茎海绵体动脉收缩期峰值流速(PSV)、右侧舒张末期流速(EDV)、右侧阻力指数(RI)、左侧PSV、左侧EDV、左侧RI比较均有统计学差异(P<0.05)。结论药物联合AVSS的RigiScan检测虽具有简便、可重复性等特点,但不能很好地区分非血管性ED和血管性ED,临床上仍需结合PCDU检查对血管性ED进一步诊断。年龄是血管性ED病情趋于加重的独立风险因素。 展开更多
关键词 勃起功能障碍 彩色多普勒超声 磷酸二酯酶5抑制剂 听视觉性刺激
下载PDF
DART-MS/MS快速检测食品中非法添加的N-苄基他达拉非等7种新型PDE-5型抑制剂 被引量:1
8
作者 任静 董培智 赵丽红 《食品与药品》 CAS 2023年第4期329-333,共5页
目的将实时直接分析离子源(direct analysis in real time,DART)与三重四极杆质谱联用,建立食品中非法添加PDE-5型抑制剂的快速筛查方法。方法3种不同基质样品加入乙腈振摇10 s后,设进样速率0.2 mm/s,进样体积4μl,选择DART离子源,离子... 目的将实时直接分析离子源(direct analysis in real time,DART)与三重四极杆质谱联用,建立食品中非法添加PDE-5型抑制剂的快速筛查方法。方法3种不同基质样品加入乙腈振摇10 s后,设进样速率0.2 mm/s,进样体积4μl,选择DART离子源,离子化温度450℃,在正离子、多反应监测(MRM)下进行检测。结果该方法7种物质的检出限为0.025~12.5μg/g,检出阳性样品4种,分别非法添加羟基卡巴地那非、环己基去甲他达拉非、N-苄基他达拉非和N-苯基丙氧苯基卡巴地那非。结论该方法样品前处理简单,分析速度快,定性准确,环境污染小,能满足食品中非法添加PDE-5型抑制剂的快速筛查要求。 展开更多
关键词 实时直接分析 三重四极杆质谱 食品 pde-5抑制剂 非法添加
下载PDF
Effects of phosphodiesterase 5 inhibitors on sperm parameters and fertilizing capacity 被引量:11
9
作者 F. Dimitriadis D. Giannakis +11 位作者 N. Pardalidis K. Zikopoulos E. Paraskevaidis N. Giotitsas V. Kalaboki P.Tsounapi D. Baltogiannis Georgiou M.Saito T.Watanabe I. Miyagawa N.Sofildtis 《Asian Journal of Andrology》 SCIE CAS CSCD 2008年第1期115-133,共19页
The aim of this review study is to elucidate the effects that phosphodiesterase 5 (PDE5) inhibitors exert on spermatozoa motility, capacitation process and on their ability to fertilize the oocyte. Second messenger ... The aim of this review study is to elucidate the effects that phosphodiesterase 5 (PDE5) inhibitors exert on spermatozoa motility, capacitation process and on their ability to fertilize the oocyte. Second messenger systems such as the cAMP/adenylate cyclase (AC) system and the cGMP/guanylate cyclase (GC) system appear to regulate sperm functions. Increased levels of intracytosolic cAMP result in an enhancement of sperm motility and viability. The stimulation of GC by low doses of nitric oxide (NO) leads to an improvement or maintenance of sperm motility, whereas higher concentrations have an adverse effect on sperm parameters. Several in vivo and in vitro studies have been carried out in order to examine whether PDE5 inhibitors affect positively or negatively sperm parameters and sperm fertilizing capacity. The results of these studies are controversial. Some of these studies demonstrate no significant effects of PDE5 inhibitors on the motility, viability, and morphology of spermatozoa collected from men that have been treated with PDE5 inhibitors. On the other hand, several studies demonstrate a positive effect of PDE5 inhibitors on sperm motility both in vivo and in vitro. In vitro studies of sildenafil citrate demonstrate a stimulatory effect on sperm motility with an increase in intracellular cAMP suggesting an inhibitory action of sildenafil citrate on a PDE isoform other than the PDE5. On the other hand, tadalafil's actions appear to be associated with the inhibitory effect of this compound on PDE11. In vivo studies in men treated with vardenafil in a daily basis demonstrated a significantly larger total number of spermatozoa per ejaculate, quantitative sperm motility, and qualitative sperm motility; it has been suggested that vardenafil administration enhances the secretory function of the prostate and subsequently increases the qualitative and quantitative motility of spermatozoa. The effect that PDE5 inhibitors exert on sperm parameters may lead to the improvement of the outcome of assisted reproductive technology (ART) programs. In the future PDE5 inhibitors might serve as adjunct therapeutical agents for the alleviation of male infertility. 展开更多
关键词 sperm fertilizing capacity phosphodiesterase 5 inhibitors SPERMATOZOA TESTIS male infertility
下载PDF
NDM-5-C208A突变大肠埃希菌的构建及大蒜辣素与NDM-5相互作用位点分析
10
作者 叶志滨 王晓明 +5 位作者 吕茜 刘雨桐 金季赜晓 朱馨艺 黄金虎 王丽平 《南京农业大学学报》 CAS CSCD 北大核心 2024年第1期61-68,共8页
[目的]产新德里金属β-内酰胺酶5(NDM-5)的革兰阴性耐药菌对人畜健康产生巨大威胁。本文旨在初步探究大蒜辣素对NDM-5的抑制作用及其相关作用位点,为临床开发新型β-内酰胺酶抑制剂提供理论支持。[方法]通过AutoDock模拟分子对接,预测... [目的]产新德里金属β-内酰胺酶5(NDM-5)的革兰阴性耐药菌对人畜健康产生巨大威胁。本文旨在初步探究大蒜辣素对NDM-5的抑制作用及其相关作用位点,为临床开发新型β-内酰胺酶抑制剂提供理论支持。[方法]通过AutoDock模拟分子对接,预测大蒜辣素与NDM-5的结合位点;构建突变型载体pET21a-NDM-5-C208A,测序验证无误后转入感受态大肠埃希菌BL21(DE3),通过药敏试验进行突变表型确认;采用微量肉汤棋盘法和时间杀菌曲线测定大蒜辣素与美罗培南对NDM-5突变型细菌的联合抑菌效果。通过体外表达突变蛋白NDM-5-C208A,建立酶活性测定体系,比较大蒜辣素对C208突变型NDM-5和野生型NDM-5酶活性的抑制效果。[结果]经测序证实NDM-5的C208A突变株BL21(DE3)pET21a-NDM-5-C208A构建成功,C208A突变株恢复了对头孢类和碳青霉烯类抗生素的敏感性,且大蒜辣素与美罗培南联用的联合抑菌指数由0.375增加至2,联用表现为独立作用而非协同作用;体外酶活测定结果显示NDM-5-C208A突变不仅使酶活性下降约85%,而且该位点突变导致大蒜辣素对NDM-5失去抑制作用。[结论]Cys208位点是维持NDM-5水解酶活性的关键位点,且大蒜辣素可通过与该位点结合发挥抑制酶活性的作用。该结果为大蒜辣素作为新型β-内酰胺酶抑制剂的开发和应用提供试验依据。 展开更多
关键词 大蒜辣素 NDM-5 美罗培南 酶抑制剂
下载PDF
Peptide Inhibitors of HIV-1 Virus Infection Based on Cullin-5 被引量:2
11
作者 ZHU Ke-tong ZHANG Xi-zhen LOU Chao-ping GUO Bo DU Juan WANG Xiao-dan WU Yong-ge KONG Wei YU Xiang-hui 《Chemical Research in Chinese Universities》 SCIE CAS CSCD 2008年第3期338-343,共6页
Virion infectivity factor(Vif) is one of the six accessory proteins of HIV-1 and is necessary for viral infectivity. Human Apolipoprotein B editing complex protein 3G(h-APOBEC3G) is a cytidine deaminase only expre... Virion infectivity factor(Vif) is one of the six accessory proteins of HIV-1 and is necessary for viral infectivity. Human Apolipoprotein B editing complex protein 3G(h-APOBEC3G) is a cytidine deaminase only expressed in "nonpermissive" cells and exhibits virus suppressive activity. With the aid of a Cullin-5 E3 ligase, Vif induces h-APOBEC3G degradation and with the destruction of this ligase, Vif is functionally inactive. Therefore, it is expected that blocking this E3 pathway would be a new therapeutic strategy against HIV-1 infection. In this article, the authors' took sequence alignment of the N-termini of Cullin-5 and three other members of the Cullin protein family, respectively. A set of small peptides has been synthesized based on the sequence comparison results and possible Vif-Cullin-5 interaction domains. Moreover, it has been demonstrated that several peptides can reduce virus infectivity in "nonpermissive" cells with a dose-responsive manner, but not in "permissive" cells. The results also indicate that the loss of viral infectivity may be because of the increase of APOBEC3G amount in the peptide-treated cells. It is concluded that peptides derived from Cullin-5 can block the APOBEC3G degradation induced by Vif and suppress HIV-1 infectivity. Therefore this study starts a novel strategy for the development of a new HIV-1 inhibitor. 展开更多
关键词 HIV-1 inhibitor PEPTIDE VIF Cullin-5 APOBEC3G
下载PDF
保健食品中西地那非等PDE-5i检测方法研究进展
12
作者 李少元 接强 +5 位作者 栾玉静 董颖 崔冠峰 黄健 孙晓宇 王芳琳 《刑事技术》 2023年第3期221-227,共7页
5型磷酸二酯酶(PDE-5)是生物体内专一水解细胞内环磷酸鸟苷(cGMP)的关键因子,具有调节血管张力、传导视觉信号、调控能量代谢等作用。5型磷酸二酯酶抑制剂(PDE-5i)作为选择性抑制磷酸二酯酶活性的一类药物,可用于改善勃起功能障碍、治... 5型磷酸二酯酶(PDE-5)是生物体内专一水解细胞内环磷酸鸟苷(cGMP)的关键因子,具有调节血管张力、传导视觉信号、调控能量代谢等作用。5型磷酸二酯酶抑制剂(PDE-5i)作为选择性抑制磷酸二酯酶活性的一类药物,可用于改善勃起功能障碍、治疗肺动脉高压等疾病,在临床上广泛应用。一些不法商家向保健食品中非法添加PDE-5i及其类似物以达到其声称的保健效果,严重危害消费者健康。本文综述了保健食品中非法添加PDE-5i及其类似物的常用检测方法,包括理化快速筛查法、酶联免疫法、胶体金免疫层析法、近红外光谱法、拉曼光谱法、离子迁移谱法、薄层色谱及其联用法、液相色谱法、液相色谱-质谱联用法等,并介绍了各个方法的特点,为市场监管部门和公安机关打击食品药品违法犯罪行为提供技术支撑。 展开更多
关键词 保健食品 5型磷酸二酯酶抑制剂(pde-5i) 西地那非 检测方法
下载PDF
A systematic review of the effects and mechanisms of preoperative 5α-reductase inhibitors on intraoperative haemorrhage during surgery for benign prostatic hyperplasia 被引量:5
13
作者 Huan-Tao Zong Xiao-Xia Peng +1 位作者 Chen-Chen Yang Yong Zhang 《Asian Journal of Andrology》 SCIE CAS CSCD 2011年第6期812-818,共7页
5α-reductase inhibitors (5α-RIs), including finasteride and dutasteride, are commonly used medical therapies for benign prostatic hyperplasia (BPH). Many studies reported that preoperative 5α-RI had impact on i... 5α-reductase inhibitors (5α-RIs), including finasteride and dutasteride, are commonly used medical therapies for benign prostatic hyperplasia (BPH). Many studies reported that preoperative 5α-RI had impact on intraoperative haemorrhage during surgery for BPH, but it was still in controversial. So, we conducted a systematic review of the effects and mechanisms of 5α-RIs on intraoperative bleeding for BPH. MEDLINE, EMBASE, the Cochrane Controlled Trail Register of Controlled Trials and the reference lists of retrieved studies were searched in the analysis. Sixteen publications involving 15 different randomized controlled trials (RCTs) and a total of 1156 patients were used in the analysis, including 10 RCTs for finasteride and five RCTs for dutasteride. We found that preoperative finasteride treatment decreases microvessel density (MVD) in resected prostate specimens. Total blood loss, blood loss per gram of resected prostate tissue and decreases in haemoglobin were all greatly reduced in the finasteride group as compared to controls. Dutasteride appeared to have no effect on bleeding. This meta-analysis shows that preoperative finasteride treatment could decrease intraoperative haemorrhage during surgery for BPH. Preoperative dutasteride had no effect on intraoperative haemorrhage, but further high-qualitv prospective studies are still needed to confirm this observation. 展开更多
关键词 5α-reductase inhibitor benign prostate hyperplasia HAEMORRHAGE META-ANALYSIS microvessel density
下载PDF
The use of 5-alpha reductase inhibitors in the treatment of benign prostatic hyperplasia 被引量:12
14
作者 Eric H.Kim John A.Brockman Gerald L.Andriole 《Asian Journal of Urology》 2018年第1期28-32,共5页
Benign prostatic hyperplasia(BPH)is characterized by an enlarged prostate,lower urinary tract symptoms(LUTS),and a decreased urinary flow rate.Common in older men,BPH is a progressive disease that can eventually lead ... Benign prostatic hyperplasia(BPH)is characterized by an enlarged prostate,lower urinary tract symptoms(LUTS),and a decreased urinary flow rate.Common in older men,BPH is a progressive disease that can eventually lead to complications including acute urinary retention(AUR)and the need for BPH-related surgery.Both normal and abnormal prostate growth is driven by the androgen dihydrotestosterone(DHT),which is formed from testosterone under the influence of 5-alpha reductase.Thus,5-alpha reductase inhibitors(5-ARIs)effectively reduce the serum and intraprostatic concentration of DHT,causing an involution of prostate tissue.Two 5-ARIs are currently available for the treatment of BPHdfinasteride and dutasteride.Both have been demonstrated to decrease prostate volume,improve LUTS and urinary flow rates,which ultimately reduces the risk of AUR and BPH-related surgery.Therefore,either alone or in combination with other BPH medications,5-ARIs are a mainstay of BPH management. 展开更多
关键词 Benign prostatic hyperplasia 5-alpha reductase inhibitors Lower urinary tract symptoms
下载PDF
Evaluation and diagnostic testing of erectile dysfunction in the era of phosphodiesterase type 5 inhibitors 被引量:1
15
作者 Kenneth Jacobsohn Run Wang 《Asian Journal of Andrology》 SCIE CAS CSCD 2007年第1期3-7,共5页
The diagnosis and treatment of erectile dysfunction has changed dramatically since the availability of safe and effective oral therapies. Unfortunately, not all men can be adequately treated in this way, and might req... The diagnosis and treatment of erectile dysfunction has changed dramatically since the availability of safe and effective oral therapies. Unfortunately, not all men can be adequately treated in this way, and might require more invasive testing to diagnose and treat the specific cause of their dysfunction. This review looks at the tests and strategies available for men who cannot be treated by oral therapy alone. 展开更多
关键词 erectile dysfunction TESTING TREATMENT DIAGNOSIS phosphodiesterase type 5 inhibitors
下载PDF
Histone deacetylase inhibitor pracinostat suppresses colorectal cancer by inducing CDK5-Drp1 signaling-mediated peripheral mitofission
16
作者 Xiao-Ling Liang Lan Ouyang +6 位作者 Nan-Nan Yu Zheng-Hua Sun Zi-Kang Gui Yu-Long Niu Qing-Yu He Jing Zhang Yang Wang 《Journal of Pharmaceutical Analysis》 SCIE CAS CSCD 2023年第10期1168-1182,共15页
Divisions at the periphery and midzone of mitochondria are two fission signatures that determine the fate of mitochondria and cells.Pharmacological induction of excessively asymmetric mitofissionassociated cell death(... Divisions at the periphery and midzone of mitochondria are two fission signatures that determine the fate of mitochondria and cells.Pharmacological induction of excessively asymmetric mitofissionassociated cell death(MFAD)by switching the scission position from the mitochondrial midzone to the periphery represents a promising strategy for anticancer therapy.By screening a series of paninhibitors,we identified pracinostat,a pan-histone deacetylase(HDAC)inhibitor,as a novel MFAD inducer,that exhibited a significant anticancer effect on colorectal cancer(CRC)in vivo and in vitro.Pracinostat increased the expression of cyclin-dependent kinase 5(CDK5)and induced its acetylation at residue lysine 33,accelerating the formation of complex CDK5/CDK5 regulatory subunit 1 and dynaminrelated protein 1(Drp1)-mediated mitochondrial peripheral fission.CRC cells with high level of CDK5(CDK5-high)displayed midzone mitochondrial division that was associated with oncogenic phenotype,but treatment with pracinostat led to a lethal increase in the already-elevated level of CDK5 in the CRC cells.Mechanistically,pracinostat switched the scission position from the mitochondrial midzone to the periphery by improving the binding of Drp1 from mitochondrial fission factor(MFF)to mitochondrial fission 1 protein(FIS1).Thus,our results revealed the anticancer mechanism of HDACi pracinostat in CRC via activating CDK5-Drp1 signaling to cause selective MFAD of those CDK5-high tumor cells,which implicates a new paradigm to develop potential therapeutic strategies for CRC treatment. 展开更多
关键词 HDAC inhibitor Pracinostat CDK5 Mitochondrial fission ACETYLATION Drp1
下载PDF
Medical therapy for clinical benign prostatic hyperplasia:α1 Antagonists,5α reductase inhibitors and their combination 被引量:4
17
作者 Cheuk Fan Shum Weida Lau Chang Peng Colin Teo 《Asian Journal of Urology》 2017年第3期185-190,共6页
Medical therapy for clinical benign prostatic hyperplasia(BPH)has advanced significantly in the last 2 decades.Many new a1 antagonists and 5a reductase inhibitors(5ARi)are now commercially available.The practicing uro... Medical therapy for clinical benign prostatic hyperplasia(BPH)has advanced significantly in the last 2 decades.Many new a1 antagonists and 5a reductase inhibitors(5ARi)are now commercially available.The practicing urologist must decide on the most appropriate medication for his patients,taking into consideration various factors like efficacy,dosing regime,adverse effects,cost,patient’s socioeconomic background,expectations,drug availability and his own clinical experience.The use of combination therapy added further to the complexity in clinical judgment when prescribing.We highlight some of the key points in prescribing a1 antagonists,5ARi and their combination,based on our viewpoints and experience as urologists in an Asian clinical setting. 展开更多
关键词 5αReductase inhibitors Adrenergicα1 receptor antagonists Drug therapy COMBINATION Prostatic hyperplasia
下载PDF
2D-QSAR Studies on Anthranilic Acid Derivatives: A Novel Class of Allosteric Inhibitors of Hepatitis C NS5B Polymerase 被引量:3
18
作者 陈可先 谢海英 李祖光 《Chinese Journal of Structural Chemistry》 SCIE CAS CSCD 2009年第10期1217-1225,共9页
Quantitative structure activity relationship (QSAR) studies were performed on 45 anthranilic acid derivatives for their potent allosteric inhibition activities of HCV NSSB polymerase. Genetic algorithm based genetic... Quantitative structure activity relationship (QSAR) studies were performed on 45 anthranilic acid derivatives for their potent allosteric inhibition activities of HCV NSSB polymerase. Genetic algorithm based genetic function approximation (GFA) method of variable selection was used to generate the model. Highly statistically significant model with r^2 = 0.966 and r^2cv = 0.951 was obtained when the number of descriptors in the equation was set to 5. High r^2pred value of 0.884 indicates the good predictive power of the best model. Spatial descriptors of radius of gyration (RadOfGration), molecular volume (Vm), length of molecule in the z dimension (Shadow-Zlength), thermodynamic descriptors of the octanol/water partition coefficient (LogP) and molecular refractivity index (MR) showed enormous contributions to HCV NS5B polymerase inhibition. The validation of the model was done by leave-one-out (LOO) test, randomization tests and external test set prediction. The model gives insight on indispensable structural requirements for the activity and can be used to design more potent analogs against HCV NSSB polymerase. 展开更多
关键词 anthranilic acid derivatives hepatitis C virus NS5B polymerase inhibitors 2D-QSAR genetic function approximation
下载PDF
PDE5 inhibitors promote recovery of peripheral neuropathy in diabetic mice 被引量:5
19
作者 Lei Wang Michael Chopp Zheng Gang Zhang 《Neural Regeneration Research》 SCIE CAS CSCD 2017年第2期218-219,共2页
Diabetes mellitus affects an estimated 422 million people worldwide.Peripheral neuropathy is one of the most common and disabling complications of diabetes.There is currently no effective treatment for diabetic neurop... Diabetes mellitus affects an estimated 422 million people worldwide.Peripheral neuropathy is one of the most common and disabling complications of diabetes.There is currently no effective treatment for diabetic neuropathy, 展开更多
关键词 PDE5 inhibitors promote recovery of peripheral neuropathy in diabetic mice
下载PDF
3D-QSAR Studies on 4-([1,2,4]Triazolo[1,5-α]pyridin-6-yl)-5(3)-(6-methylpyridin-2-yl)imidazole Analogues as Potent Inhibitors of Transforming Growth Factor-β Type Ⅰ Receptor Kinase 被引量:1
20
作者 孙丽倩 孟利强 +5 位作者 闫超群 崔东晓 苗俊秋 陈景润 梁泰刚 李青山 《Chinese Journal of Structural Chemistry》 SCIE CAS CSCD 2018年第4期517-530,共14页
The transforming growth factor-β (TGF-β) plays a crucial role in the beginning andprogression of fibrosis in various organ systems such as lung, heart, liver and kidney. TGF-fl type Ireceptor kinase (activin rece... The transforming growth factor-β (TGF-β) plays a crucial role in the beginning andprogression of fibrosis in various organ systems such as lung, heart, liver and kidney. TGF-fl type Ireceptor kinase (activin receptor-like kinase 5, ALK5) inhibitors might have potential activity forthe treatment of relevant diseases. In this paper, the three-dimensional quantitativestructure-activity relationship (3D-QSAR) including comparative molecular field analysis (CoMFA)and comparative molecular similarity indices analysis (CoMSIA) were used to analyze thestructural requirements based on a dataset of 123 4-([1,2,4]Triazolo[1,5-a]pyridine-6-yl)-5(3)-(6-methylpyridin-2-yl)imidazole analogues which acted as ALK5 inhibitors. The obtainedCoMFA model (q2= 0.652, r2= 0.876, r2pred = 0.845) and CoMSIA model (q^2= 0.648, r^2= 0.884,r^2pred = 0.853) were robust and satisfactory. The predictive ability of the derived models wasvalidated using a test set of 28 compounds. Additionally, potentially important structural featuresrequired to enhance activity were also elucidated by the contour maps derived from CoMFA andCoMSIA models. The results will be helpful to guide drug design strategies aimed at obtainingpotent and selective ALK5 inhibitors. 展开更多
关键词 3D-QSAR COMFA COMSIA TGF-β ALK5 inhibitor
下载PDF
上一页 1 2 34 下一页 到第
使用帮助 返回顶部